JP2025107171A5 - - Google Patents

Info

Publication number
JP2025107171A5
JP2025107171A5 JP2025029903A JP2025029903A JP2025107171A5 JP 2025107171 A5 JP2025107171 A5 JP 2025107171A5 JP 2025029903 A JP2025029903 A JP 2025029903A JP 2025029903 A JP2025029903 A JP 2025029903A JP 2025107171 A5 JP2025107171 A5 JP 2025107171A5
Authority
JP
Japan
Prior art keywords
fam3b
pharmaceutical composition
vector
polynucleotide
seq
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2025029903A
Other languages
English (en)
Japanese (ja)
Other versions
JP2025107171A (ja
Filing date
Publication date
Priority claimed from GBGB1906052.4A external-priority patent/GB201906052D0/en
Application filed filed Critical
Publication of JP2025107171A publication Critical patent/JP2025107171A/ja
Publication of JP2025107171A5 publication Critical patent/JP2025107171A5/ja
Pending legal-status Critical Current

Links

JP2025029903A 2019-04-30 2025-02-27 心臓保護的活性のあるタンパク質 Pending JP2025107171A (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GBGB1906052.4A GB201906052D0 (en) 2019-04-30 2019-04-30 Proteins with cardioprotective activity
GB1906052.4 2019-04-30
JP2021564417A JP7707075B2 (ja) 2019-04-30 2020-04-30 心臓保護的活性のあるタンパク質
PCT/EP2020/062156 WO2020221906A1 (en) 2019-04-30 2020-04-30 Proteins with cardioprotective activity

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2021564417A Division JP7707075B2 (ja) 2019-04-30 2020-04-30 心臓保護的活性のあるタンパク質

Publications (2)

Publication Number Publication Date
JP2025107171A JP2025107171A (ja) 2025-07-17
JP2025107171A5 true JP2025107171A5 (https=) 2025-10-09

Family

ID=66589570

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2021564417A Active JP7707075B2 (ja) 2019-04-30 2020-04-30 心臓保護的活性のあるタンパク質
JP2025029903A Pending JP2025107171A (ja) 2019-04-30 2025-02-27 心臓保護的活性のあるタンパク質

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2021564417A Active JP7707075B2 (ja) 2019-04-30 2020-04-30 心臓保護的活性のあるタンパク質

Country Status (25)

Country Link
US (3) US12569574B2 (https=)
EP (2) EP4389211A3 (https=)
JP (2) JP7707075B2 (https=)
KR (1) KR20220027829A (https=)
CN (2) CN113795504B (https=)
AU (1) AU2020267029A1 (https=)
BR (1) BR112021021626A2 (https=)
CA (1) CA3137662A1 (https=)
DK (1) DK3962534T3 (https=)
ES (1) ES2975422T3 (https=)
FI (1) FI3962534T3 (https=)
GB (1) GB201906052D0 (https=)
HR (1) HRP20240441T1 (https=)
HU (1) HUE066324T2 (https=)
IL (1) IL287525A (https=)
LT (1) LT3962534T (https=)
MX (2) MX2021013298A (https=)
PL (1) PL3962534T3 (https=)
PT (1) PT3962534T (https=)
RS (1) RS65469B1 (https=)
SG (1) SG11202111267WA (https=)
SI (1) SI3962534T1 (https=)
SM (1) SMT202400151T1 (https=)
WO (1) WO2020221906A1 (https=)
ZA (2) ZA202107778B (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201906052D0 (en) 2019-04-30 2019-06-12 Int Centre For Genetic Engineering And Biotechnology Proteins with cardioprotective activity
WO2025253097A1 (en) * 2024-06-03 2025-12-11 Forcefield Therapeutics Limited Proteins with cardiopreservation activity

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002008284A2 (en) * 2000-07-20 2002-01-31 Genentech, Inc. Compositions and methods for the diagnosis and treatment of disorders involving angiogenesis
WO2004084800A2 (en) 2002-08-29 2004-10-07 Pfizer Products Inc. A3 receptor-mediated cardioprotective proteins and therapeutic and diagnostic methods of use
US7312079B1 (en) * 2005-10-06 2007-12-25 Lexicon Pharmaceuticals, Inc. Variants of FAM3C
ES2714007T3 (es) 2007-04-09 2019-05-24 Univ Florida Composiciones de vectores rAAV que tienen proteínas de la cápside modificadas en tirosina y métodos para su uso
WO2011094137A1 (en) * 2010-01-26 2011-08-04 Ngm Biopharmaceuticals, Inc. Methods of treating glucose metabolism disorders
US8609612B2 (en) 2010-02-12 2013-12-17 Ngm Biopharmaceuticals, Inc. Methods of treating glucose metabolism disorders
ES2777002T3 (es) 2011-09-30 2020-08-03 Somalogic Inc Predicción de eventos de riesgo cardiovascular y usos de la misma
ITRM20110685A1 (it) 2011-12-23 2013-06-24 Internat Ct For Genetic En Gineering And Microrna per la rigenerazione cardiaca attraverso l induzione della proliferazione dei miociti cardiaci
EP2981334A4 (en) 2013-04-03 2016-11-23 Univ California COMPOSITIONS AND METHODS FOR INHIBITING VIRAL ACTIVITY
US20170209621A1 (en) 2016-01-21 2017-07-27 The Board Of Trustees Of The Leland Stanford Junior University Use of chordin-like 1 or collagen vi with mesenchymal stem cells
KR102022021B1 (ko) 2018-01-10 2019-09-18 한국과학기술연구원 심혈관 질환의 진단을 위한 바이오마커 및 이의 용도
GB201906052D0 (en) 2019-04-30 2019-06-12 Int Centre For Genetic Engineering And Biotechnology Proteins with cardioprotective activity

Similar Documents

Publication Publication Date Title
JP2025107171A5 (https=)
JP2001520238A5 (https=)
JP2021121638A5 (https=)
JP2025184979A5 (https=)
JP2022520232A5 (https=)
JP2005505286A5 (https=)
JP2022513308A5 (https=)
JP2024511163A5 (https=)
KR20140104994A (ko) 인간 인슐린 유사체 및 이의 아실화 유도체
JPS60192598A (ja) 心房ペプチド
KR20160137908A (ko) 당뇨병-연관 심기능 장애 및 울혈성 심부전을 치료하기 위한 우로코르틴-2 및 연관 유전자들을 인코딩하는 바이러스 벡터들의 전신 전달
IL298772A (en) Coding-optimized nucleic acid encoding the SMN1 protein and its use
JP2024513907A5 (https=)
EP3778629B1 (en) Application of ryr2 protein or recombinant ryr2 protein in preparing anti-heart failure medicament
JP2002539781A5 (https=)
PT98695A (pt) Gene codificador do factor neurotrofico de ligacao a heparina
JP2024503091A5 (https=)
JP2022530168A5 (https=)
CN117899223B (zh) 以nup35基因和或以nup35蛋白作为作用靶点的物质的应用及组合物
FI3962534T3 (fi) Proteiineja, joilla on kardioprotektiivinen vaikutus
WO2026017126A1 (zh) 一种人工设计的新型nrg-1在疾病治疗中的应用
Pring-kerblom et al. The hexon genes of adenoviruses of subgenus C: comparison of the variable regions
WO2000065043A1 (fr) Utilisation d'adenovirus recombinant defectif comprenant un acide nucleique codant pour un facteur angiogenique pour le traitement de l'hypertension arterielle pulmonaire
CN103173451B (zh) 一种心肌特异启动子
JP2022530359A5 (https=)